Catheter Precision Inc. (VTAK) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE MKT

Key Metrics

• Price: $1.61
• Market Cap: $3.05M
• P/E Ratio: 0.06
• EPS: $33.63
• 52-Week High: $15.77
• 52-Week Low: $1.14

Market Sentiment

Catheter Precision Inc. currently has a Bullish sentiment score of 0.28.

About Catheter Precision Inc.

Catheter Precision, Inc. is a leading medical technology firm headquartered in Fort Mill, South Carolina, focused on advancing electrophysiology solutions aimed at improving the management and treatment of cardiac arrhythmias. The company is committed to enhancing clinical outcomes through its innovative products, which are specifically designed for patients, healthcare providers, and hospitals. By leveraging cutting-edge technology and a precision-driven approach, Catheter Precision stands a...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Catheter Precision Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VTAK pay dividends?

Catheter Precision Inc. (VTAK) does not currently pay a regular dividend.

What is VTAK's P/E ratio?

Catheter Precision Inc. has a price-to-earnings (P/E) ratio of 0.06.

What is VTAK's market cap?

Catheter Precision Inc. (VTAK) has a market capitalization of $3.05M with a current stock price of $1.61.